The estimated Net Worth of Stephen P Macmillan is at least $122 Millón dollars as of 30 July 2024. Mr. Macmillan owns over 44,039 units of Hologic stock worth over $96,140,096 and over the last 21 years he sold HOLX stock worth over $13,014,205. In addition, he makes $12,374,800 as Chairman of the Board, President y Chief Executive Officer at Hologic.
Sign up
Mr. MacMillan HOLX stock SEC Form 4 insiders trading
Stephen has made over 25 trades of the Hologic stock since 2004, according to the Form 4 filled with the SEC. Most recently he exercised 44,039 units of HOLX stock worth $1,154,262 on 30 July 2024.
The largest trade he's ever made was exercising 355,427 units of Hologic stock on 6 December 2016 worth over $28,437,714. On average, Stephen trades about 15,109 units every 58 days since 2003. As of 30 July 2024 he still owns at least 1,201,601 units of Hologic stock.
You can see the complete history of Mr. Macmillan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Stephen MacMillan biography
Stephen P. MacMillan serves as Chairman of the Board, President, Chief Executive Officer of the Company. Mr. MacMillan was appointed as President, Chief Executive Officer and a director in December 2013 and was elected Chairman of the Board in June 2015. From October 2012 to December 2013, Mr. MacMillan was the Chief Executive Officer of sBioMed, LLC, a biomedical research company. From 2003 to 2012, he served in various roles at Stryker Corporation, including Chief Operating Officer from 2003 to 2005, Chief Executive Officer from 2005 to 2012 and Chairman from 2010 to 2012. Prior to 2003, Mr. MacMillan was a senior executive with Pharmacia Corporation, where he oversaw five global businesses. Prior to joining Pharmacia, Mr. MacMillan spent 11 years with Johnson & Johnson in a variety of senior roles in both the U.S. and Europe, including as President of its consumer pharmaceuticals joint venture with Merck. Mr. MacMillan began his career with Procter & Gamble in 1985. Mr. MacMillan currently serves on the Board of Trustees of Davidson College. Mr. MacMillan holds a Bachelor of Arts degree in economics from Davidson College, and is a graduate of Harvard Business School’s Advanced Management Program.
What is the salary of Stephen MacMillan?
As the Chairman of the Board, President y Chief Executive Officer of Hologic, the total compensation of Stephen MacMillan at Hologic is $12,374,800. There are no executives at Hologic getting paid more.
How old is Stephen MacMillan?
Stephen MacMillan is 56, he's been the Chairman of the Board, President y Chief Executive Officer of Hologic since 2015. There are 9 older and 9 younger executives at Hologic. The oldest executive at Hologic, Inc. is Dr. Jay A. Stein, 78, who is the Co-Founder, Chairman Emeritus, CTO & Sr. VP.
What's Stephen MacMillan's mailing address?
Stephen's mailing address filed with the SEC is Campus Drive, Marlborough, Middlesex County, Massachusetts, 01752, United States.
Insiders trading at Hologic
Over the last 30 years, insiders at Hologic have traded over $311,276,394 worth of Hologic stock and bought 385,967 units worth $8,452,795 . The most active insiders traders include Carl Chigh River Limited Pa..., Carl C Icahn y Stephen P Macmillan. On average, Hologic executives and independent directors trade stock every 22 days with the average trade being worth of $3,042,940. The most recent stock trade was executed by Karleen Marie Oberton on 29 August 2024, trading 52,679 units of HOLX stock currently worth $4,243,820.
What does Hologic do?
driven by our ethos, the science of sure, we’re a diverse, dedicated, creative team that develops, markets and services some of the most innovative and accurate diagnostic imaging systems and surgical products on the planet. while we’re focused and passionate about our work, we never forget that what we’re really doing is giving people greater confidence and peace of mind in their diagnosis—enabling healthier lives, everywhere, every day. connect with us at hologic.com, on facebook at facebook.com/hologicjobs, and on twitter @hologic_jobs.
What does Hologic's logo look like?
Complete history of Mr. Macmillan stock trades at Hologic, Illumina Inc, Texas Instruments, Boston Scientific y Stryker
Hologic executives and stock owners
Hologic executives and other stock owners filed with the SEC include:
-
Stephen MacMillan,
Chairman of the Board, President, Chief Executive Officer -
Stephen P. MacMillan,
Chairman, CEO & Pres -
Kevin Thornal,
Division President, Diagnostics -
John Griffin,
General Counsel -
Peter Valenti,
Division President - Breast and Skeletal Health -
Karleen Oberton,
Chief Financial Officer -
Kevin R. Thornal,
Division Pres of Diagnostic Solutions -
John M. Griffin,
Gen. Counsel -
Sean S. Daugherty,
Group Pres of Breast/Skeletal Health & GYN Surgical Solutions -
Sally Crawford,
Lead Independent Director -
Ludwig Hantson,
Independent Director -
Charles Dockendorff,
Independent Director -
Scott Garrett,
Independent Director -
Namal Nawana,
Independent Director -
Amy Wendell,
Independent Director -
Christiana Stamoulis,
Independent Director -
Michael Watts,
Vice President - Investor Relations and Corporate Communications -
Allison Bebo,
Senior Vice President - Human Resources -
Mike Kelly,
Chief Supply Chain Officer and Corp. VP of Quality Assurance & Regulatory Affairs -
Paul Malenchini,
Chief Information Officer -
Elisabeth A. Hellmann,
Sr. VP of Global HR & Corp. Communications -
Ryan Simon,
VP of Investor Relations -
Monica Aguirre Berthelot,
Chief of Staff -
Sanjay Prabhakaran,
Regional Pres of Asia Pacific -
Jan Verstreken,
Group Pres of International -
Dr. Jay A. Stein,
Co-Founder, Chairman Emeritus, CTO & Sr. VP -
Elaine Ullian,
Director -
Nancy Leaming,
Director -
Thomas A. West,
Div President & GM, Diagnostic -
Christopher J Coughlin,
Director -
Eric B. Compton,
COO -
Robert W. Mc Mahon,
Chief Financial Officer -
Lawrence M Levy,
Director -
Carl Hull,
SVP and GM of Diagnostics -
Peter Soltani,
Vice President -
Benjamin Jordan Cohn,
Principal Accounting Officer -
Steven S. Williamson,
SVP, GYN Surgical -
John R Pekarsky,
Sr. VP, Sales -
Howard Jr Doran,
Vice President & BUD, ThinPrep -
Arthur G Lerner,
Director -
Laurie Fajardo,
Director -
Robert Cascella,
President & COO -
William A Peck,
Director -
Stuart A Kingsley,
President, Surgical Division -
Irwin Jacobs,
Director -
C William Mcdaniel,
Director -
Stetten Eric Von,
Vice President -
Daniel J Levangie,
Director -
Patrick J Sullivan,
Director -
Wayne Wilson,
Director -
Jay A Stein,
Director -
Samuel J. Merksamer,
Director -
Jonathan Christodoro,
Director -
David R Jr Lavance,
Director -
Claus Egstrand,
SVP and GM, International -
Carl Chigh River Limited Pa...,
-
Rohan Hastie,
Group VP & GM, Diagnostics -
Roger D. Mills,
SVP & GM, Service & Operations -
Robert H Lavallee,
Vice President -
Mark J Casey,
Senior V.P & General Counsel -
Carl C Icahn,
10% owner -
David Harding,
SVP, International -
David J Brady,
SVP, Human Resources -
Glenn P Muir,
Executive VP & CFO -
John W Cumming,
Chairman & CEO -
Sean S. Daugherty,
Group President, BSH & Surg. -
Jan Verstreken,
Group President, International -
Nanaz Mohtashami,
Director -
Brandon Schnittker,
Div. President, GYN Surgical -
Elisabeth A Hellmann,
SVP, Human Resources -
Erik S Anderson,
Div. Pres., Breast & Skeletal -
Essex D Mitchell,
Div. President, GYN Surgical -
Stacey D. Stewart,
Director -
Jennifer M Schneiders,
President, Diag. Solutions -
Peter Paul Dunne,
SVP, Human Resources